1-1 of 1
Robert Leipold
Close
Sort by
Journal Articles

Cost-Effectiveness of CPX-351 Versus 7+3 Regimen in the Treatment of Treatment-Related Acute Myeloid Leukemia (tAML) or AML with Myelodysplasia-Related Changes (MRC)

Anuraag Kansal, Mark Du, Oscar Herrera-Restrepo, Robert Leipold, Robert J. Ryan, Arthur C. Louie, Karen Chung
Journal: Blood
Blood (2017) 130 (Supplement 1): 4674.
https://doi.org/10.1182/blood.V130.Suppl_1.4674.4674
Published: 2017